Suppr超能文献

评价用于检测血清抗副球孢子菌抗体的商业免疫扩散试剂。

Evaluation of commercial immunodiffusion reagents for detecting serum anti-Paracoccidioides antibodies.

机构信息

Universidade Federal do Paraná, Hospital de Clínicas, Curitiba, PR, Brasil.

Center of Expertise in Mycology Radboudumc/CWZ. Nijmegen, the Netherlands.

出版信息

Rev Soc Bras Med Trop. 2024 May 27;57:e007052024. doi: 10.1590/0037-8682-0094-2024. eCollection 2024.

Abstract

BACKGROUND

Accurate diagnosis of paracoccidioidomycosis is crucial for improving patient outcomes. Paracoccidioides antibody detection by double immunodiffusion (DID) is a convenient diagnostic tool, but testing performance can vary based on certain factors.

METHODS

We assessed DID performance using a commercially prepared Paracoccidioides reagents (IMMY, USA), involving 40 serum specimens, including 20 from patients with proven paracoccidioidomycosis and 20 from patients without the disease. The DID test demonstrated a sensitivity of 90% (95% CI=68%-99%) and a specificity of 100% (95% CI=83%-100%).

CONCLUSIONS

Our findings suggest that DID using commercial reagents may provide a feasible tool with satisfactory testing performance for anti-Paracoccidioides antibody detection.

摘要

背景

准确诊断球孢子菌病对于改善患者预后至关重要。双扩散免疫检测(DID)检测对球孢子菌的抗体是一种便捷的诊断工具,但检测性能可能因某些因素而异。

方法

我们使用商业制备的球孢子菌试剂(IMMY,美国)评估 DID 的性能,涉及 40 份血清标本,包括 20 份来自确诊球孢子菌病患者的标本和 20 份来自无该疾病患者的标本。DID 试验的敏感性为 90%(95%CI=68%-99%),特异性为 100%(95%CI=83%-100%)。

结论

我们的研究结果表明,使用商业试剂的 DID 可能为抗球孢子菌抗体检测提供一种可行的、具有满意检测性能的工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e23/11136505/e3355794c895/1678-9849-rsbmt-57-e00705-2024-gf1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验